MIP-1α, a member of the CC chemokine subfamily, is upregulated at early acute stages of cerebral ischemia and may have a role in promoting inflammatory and/or repair processes in ischemic brain [62]; at later stages, this chemokine can also serve as a chemoattractant for stem cell migration after ischemic injury [63]. The gene discussed is CCL3; the disease is brain ischemia.